Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pittsburgh, PA
NPI
1053383224
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
420 E North Ave, Suite 205
Pittsburgh, PA, 15212
Phone (412) 359-3426
Groups this clinician bills Medicare through
Medicare paid, 2024
$349K
4,255 services
Medicare patients, 2024
1,014
Average age 72
Drug cost, 2024
$7.9M
21,050 prescriptions
Company payments, 2025
$3,315
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hemlata Moturi was code 99214 (office e&m - established), 1,599 times for 678 patients. In total Hemlata Moturi billed 4,255 services in 19 codes, and Medicare paid $349K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,599 | 678 | $85.29 | $136K |
| 99232 Hospital E&M - Subsequent | Facility | 1,043 | 190 | $58.47 | $61K |
| 99215 Office E&M - Established | Office | 522 | 301 | $117.99 | $62K |
| 99233 Hospital E&M - Subsequent | Facility | 355 | 173 | $88.06 | $31K |
| 99223 Hospital E&M - Initial | Facility | 208 | 197 | $126.85 | $26K |
| 99213 Office E&M - Established | Office | 112 | 66 | $56.37 | $6,314 |
| 95251 Test - Miscellaneous | Office | 82 | 42 | $25.58 | $2,098 |
| 96372 Injection Administration | Office | 78 | 46 | $8.90 | $694 |
| 99222 Hospital E&M - Initial | Facility | 67 | 63 | $97.36 | $6,523 |
| 99204 Office E&M - New | Office | 52 | 52 | $116.13 | $6,039 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 49 | 36 | $0.85 | $41.74 |
| 99205 Office E&M - New | Office | 44 | 44 | $149.15 | $6,563 |
| 99214 Office E&M - Established | Facility | 23 | 16 | $66.85 | $1,538 |
By year: 2022 $200K for 2,625 services; 2023 $320K for 3,976 services; 2024 $349K for 4,255 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hemlata Moturi prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,776 prescriptions and refills. In total Hemlata Moturi wrote 21,050 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,776 | 6,328 | 637 | $28K |
| Synthroid Levothyroxine Sodium | 1,691 | 3,972 | 394 | $137K |
| Metformin Hcl Generic | 922 | 2,154 | 252 | $6,703 |
| Ozempic Semaglutide | 871 | 1,325 | 184 | $1.2M |
| Rosuvastatin Calcium Generic | 757 | 1,769 | 209 | $9,093 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 727 | 1,563 | 208 | $124K |
| Hydrocortisone Generic | 666 | 1,501 | 173 | $37K |
| Glimepiride Generic | 662 | 1,538 | 176 | $9,081 |
| Atorvastatin Calcium Generic | 660 | 1,700 | 191 | $7,223 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 495 | 1,336 | 177 | $4,771 |
| Mounjaro Tirzepatide | 423 | 555 | 80 | $586K |
| Lisinopril Generic | 385 | 900 | 103 | $2,529 |
| Jardiance Empagliflozin | 354 | 660 | 96 | $369K |
| Losartan Potassium Generic | 337 | 734 | 85 | $2,790 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 336 | 793 | 143 | $44K |
Brand drugs: 8,176 claims; generic drugs: 11,737 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hemlata Moturi $3,315 ($3,315 in general payments such as food, travel and fees) from 35 companies. The largest payer was Novo Nordisk Inc with $541.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 19 | $541 |
| Amgen Inc. AMGN | 10 | $335 |
| Lilly USA, LLC LLY | 15 | $332 |
| CeQur Corporation | 1 | $229 |
| Dexcom, Inc. DXCM | 7 | $148 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $137 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $90.82 |
| Antares Pharma, Inc. | 5 | $89.82 |
| Alvogen Inc | 2 | $87.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.